Phenobarbital Elixir
(Current title—not to change until June 1,2005)
Monograph title change—to become official June 1,2005
See Phenobarbital Oral Solution
»Phenobarbital Elixir contains not less than 90.0percent and not more than 110.0percent of the labeled amount of C12H12N2O3.
Packaging and storage— Preserve in tight,light-resistant containers.
Identification—
A: Place 10mLof Elixir in a separator containing 20mLof water,add 5mLof 1Nsodium hydroxide,and extract with two 10-mLportions of chloroform,discarding the chloroform extracts.Add 5mLof 3Nhydrochloric acid,and extract with two 25-mLportions of chloroform,filtering the extracts through paper into a beaker.Remove the chloroform by evaporation on a steam bath,and dry the residue at 105for 2hours:the residue so obtained responds to Identificationtest Aunder Phenobarbital.
B: The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that of the Standard preparation,both relative to the internal standard,as obtained in the Assay.
Alcohol content,Method IIá611ñ: between 12.0%and 15.0%of C2H5OH.
Assay—
pH4.5Buffer solution,Mobile phase,andChromatographic system— Prepare as directed in the Assayunder Phenobarbital.
Diluent— Prepare a mixture of methanol and pH4.5Buffer solution(2:1).
Internal standard solution— Dissolve a sufficient quantity of caffeine in Diluentto obtain a solution having a concentration of about 1.7mg per mL.
Standard preparation— Transfer about 33mg of USP Phenobarbital RS,accurately weighed,to a 25-mLvolumetric flask containing 2.0mLof Internal standard solution.Dilute with Diluentto volume,and mix.
Assay preparation— Transfer a quantity of Elixir,equivalent to about 33mg of phenobarbital,to a 25-mLvolumetric flask containing 2.0mLof Internal standard solution.Dilute with Diluentto volume,and mix.
Procedure— Proceed as directed for Procedurein the Assayunder Phenobarbital.Calculate the quantity,in mg,of C12H12N2O3in the portion of the Elixir taken by the formula:
W(RU/RS),
in which the terms are as defined therein.
Auxiliary Information— Staff Liaison:Ravi Ravichandran,Ph.D.,Senior Scientist
Expert Committee:(PA3)Pharmaceutical Analysis 3
USP28–NF23Page 1530
Pharmacopeial Forum:Volume No.28(2)Page 343
Phone Number:1-301-816-8330